Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.4B | 2.8B | 2.2B | 2.0B |
| Cost of revenue | 1.2B | 1.5B | 1.0B | 1B |
| Gross profit | 1.2B | 1.4B | 1.1B | 1.0B |
| Operating expense | ||||
| Research & development | 377M | 351M | 332M | 349M |
| Selling general and admin | 514M | 460M | 445M | 413M |
| Other operating expenses | 75M | 76M | 58M | 42M |
| Operating income | 203M | 465M | 283M | 241M |
| Non operating interest income | ||||
| Income | 65M | 72M | 77M | 80M |
| Expense | — | — | — | — |
| Other income expense | -1.0B | 884M | 500M | -118M |
| Pretax income | -770M | 1.4B | 860M | 203M |
| Tax provision | -88M | 128M | 32M | 32M |
| Net income | -682M | 1.3B | 828M | 171M |
| Basic EPS | -0.5 | 1.0 | 0.6 | 0.1 |
| Diluted EPS | -0.5 | 1.0 | 0.6 | 0.1 |
| Basic average shares | 930.7M | 928.8M | 926.0M | 924.8M |
| Diluted average shares | 930.7M | 928.8M | 933.9M | 932.7M |
| EBITDA | 1.2B | -433M | -237M | 369M |
| Net income from continuing op. | -682M | 1.3B | 828M | 171M |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |